Kerentech

Kerentech is a leading venture capital and private equity firm, dedicated to fostering growth and innovation within the life sciences and medtech industries. With extensive experience in facilitating outlicensing, joint ventures, and M&A transactions, Kerentech connects companies with strategic investors to drive impactful advancements in healthcare. Kerentech operates globally, serving clients in key markets such as the United States, United Kingdom, France, Israel, Spain, India, and China. Kerentech maintains a strong presence with offices located at 19 Ha Lamed Hey St, Jerusalem, Israel 9366125, IL, and 19 Ha Lamed Hey, Jerusalem, 93661, IL.

Kerentech specializes in providing comprehensive business development support related to pharma, biotech, and medtech, including IP trade and negotiation. Kerentech focuses on companies with protected IP and proven concepts, facilitating fundraising for drug development and medtech ventures. With a wealth of experience ranging from start-ups to NASDAQ-listed companies, Kerentech is well-equipped to handle phase III transactions and fundraising for incubators and specialized life science funds.

Kerentech leverages its extensive network and deep industry knowledge to help companies achieve their strategic objectives and accelerate their growth trajectories. Kerentech is committed to driving innovation and creating value for its clients and partners. We invite the management team at Kerentech to create a customized and exclusive company showcase and product listing on our platform to further enhance your visibility and reach within the industry.